Revenue and Profitability - The company's revenue for Q3 2025 was ¥49,154,073.11, representing a decrease of 3.84% compared to the same period last year[4] - The net profit attributable to shareholders was -¥9,629,025.82, an increase of 83.76% year-over-year, indicating a significant reduction in losses[4] - The net profit after deducting non-recurring gains and losses was -¥10,212,674.54, reflecting an improvement of 82.11% compared to the previous year[4] - Total operating revenue for the current period is ¥150,251,165.81, a decrease of 33.7% compared to ¥226,974,223.85 in the previous period[18] - Net profit for the current period is -¥54,455,800.70, an improvement from -¥172,552,001.92 in the previous period, indicating a 68.4% reduction in losses[19] - Total comprehensive income for the current period is -¥54,922,333.36, compared to -¥175,251,621.30 in the previous period, reflecting a 68.7% improvement[20] - Basic and diluted earnings per share are both -¥0.0756, an improvement from -¥0.2295 in the previous period[20] Assets and Liabilities - Total assets at the end of the reporting period were ¥1,700,343,636.82, down 9.39% from the end of the previous year[4] - The company's total assets decreased from CNY 1,876,510,196.66 at the beginning of the period to CNY 1,700,343,636.82 by the end of the period, reflecting a decline of approximately 9.36%[14] - Current assets fell from CNY 606,035,963.51 to CNY 445,951,737.46, a decrease of about 26.39%[14] - Cash and cash equivalents decreased significantly from CNY 51,546,819.84 to CNY 20,701,820.54, representing a decline of approximately 59.93%[14] - Accounts receivable dropped from CNY 270,944,669.40 to CNY 200,421,962.14, a reduction of about 26.00%[14] - Total liabilities decreased from CNY 1,698,812,455.71 to CNY 1,577,160,814.38, a decline of approximately 7.15%[16] - Current liabilities also saw a decrease from CNY 1,003,898,014.65 to CNY 871,372,379.44, reflecting a reduction of about 13.14%[16] - The company's equity attributable to shareholders decreased from CNY 177,697,740.95 to CNY 123,182,822.44, a decline of approximately 30.66%[17] - The company’s total non-current liabilities increased slightly from CNY 694,914,441.06 to CNY 705,788,434.94, an increase of about 1.25%[16] Cash Flow and Expenses - Cash flow from operating activities for the year-to-date was ¥38,229,369.27, a decline of 11.43% compared to the same period last year[8] - Cash flow from operating activities generated ¥38,229,369.27, down from ¥43,161,103.87, a decrease of 4.3%[22] - Cash and cash equivalents at the end of the period stand at ¥4,110,428.28, compared to ¥762,432.07 at the end of the previous period, showing a significant increase[23] - The company reported a significant reduction in sales expenses, which decreased by 78.14% to ¥4,208,211.12 due to effective cost control measures[8] - Research and development expenses were reduced by 59.27% to ¥8,888,510.79, reflecting a decrease in investment in this area[8] - Research and development expenses decreased to ¥8,888,510.79 from ¥21,823,424.04, a reduction of 59.3%[18] - The company experienced a 158.44% increase in credit impairment losses, amounting to ¥7,315,710.16, primarily due to changes in the consolidation scope[8] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 83,407[10] Other Information - The company reported a significant increase in other income to ¥3,582,903.78 from ¥3,225,742.09, an increase of 11.1%[19] - The company has not undergone an audit for the third quarter financial report[24]

Financial Performance - The company's operating revenue for Q3 2025 was ¥2,842,130,162.05, representing a year-on-year increase of 7.31%[5] - Net profit attributable to shareholders for Q3 2025 was ¥255,898.06, a significant increase of 100.91% compared to the same period last year[5] - The net profit attributable to shareholders after deducting non-recurring gains and losses was -¥5,276,830.53, a decrease of 85.25% year-on-year[5] - The company reported a 14.89% decrease in operating revenue for the first nine months of 2025, totaling ¥7,252,057,632.04, primarily due to a decline in internet business[9] - Total operating revenue for the current period is ¥7,252,057,632.04, a decrease of 15% compared to ¥8,521,235,454.13 in the previous period[19] - Net profit for the current period is ¥15,160,878.41, compared to a net loss of ¥2,760,564.49 in the previous period, indicating a significant turnaround[20] - The company reported a basic earnings per share of ¥0.0035, recovering from a loss of ¥0.0306 per share in the previous period[21] Assets and Liabilities - Total assets as of September 30, 2025, amounted to ¥3,877,506,421.98, reflecting a 2.85% increase from the end of the previous year[5] - Total current assets amount to ¥2,327,511,466.92, an increase from ¥2,153,454,134.30 at the beginning of the period[15] - Total liabilities increased to ¥1,703,209,693.82 from ¥1,589,575,154.29, marking an increase of approximately 7.1%[17] - The company’s total liabilities increased by 87.35% to ¥289,665,529.46 due to new borrowings during the period[9] - Total current liabilities increased to ¥1,574,171,559.18 from ¥1,425,963,975.90[16] - Short-term borrowings rose significantly to ¥289,665,529.46 from ¥154,615,566.39, indicating a rise of approximately 87.2%[16] - Long-term borrowings decreased to ¥78,081,069.96 from ¥114,903,863.44[16] Cash Flow - The company’s cash flow from operating activities for the year-to-date was -¥80,375,739.74, a decline of 137.40% compared to the same period last year[9] - Cash flow from operating activities shows a net outflow of ¥80,375,739.74, contrasting with a net inflow of ¥214,935,234.64 in the previous period[22] - Net cash flow from investing activities was $12.21 million, a significant improvement from a net outflow of $92.09 million in the previous period[23] - Cash inflow from financing activities totaled $595.58 million, compared to $304.49 million in the prior period, indicating a 95.4% increase[23] - Net cash flow from financing activities was $83.18 million, recovering from a net outflow of $86.44 million in the previous period[23] - The total cash and cash equivalents at the end of the period amounted to $527.40 million, down from $763.47 million year-over-year[23] - Cash outflow for investing activities was $540.31 million, a decrease from $875.00 million in the previous period[23] - Cash outflow for financing activities was $512.41 million, compared to $390.93 million in the prior period, reflecting a 31.1% increase[23] - The net increase in cash and cash equivalents for the period was $27.48 million, compared to $32.35 million in the previous period[23] Shareholder Information - Total number of common shareholders at the end of the reporting period is 179,178[12] - The largest shareholder, Li Yuelun, holds 9.65% of shares, totaling 78,262,700 shares[12] Other Financial Metrics - The company received government subsidies amounting to ¥4,614,643.30 in Q3 2025, contributing to its financial performance[6] - The company’s basic earnings per share for Q3 2025 was ¥0.0003, an increase of 100.86% year-on-year[5] - The company recorded a decrease in research and development expenses to ¥87,680,259.20 from ¥108,793,447.16, a reduction of approximately 19.4%[19] - Other comprehensive income attributable to the parent company showed a negative net amount of ¥23,723,149.76, worsening from a negative ¥15,231,839.29 in the previous period[21] - The company achieved investment income of ¥15,478,405.82, slightly down from ¥16,377,211.81 in the previous period[19] - The impact of exchange rate changes on cash and cash equivalents was a positive $12.47 million, contrasting with a negative impact of $4.05 million in the previous period[23] - The company’s cash outflow for the acquisition of fixed assets and intangible assets was $85.29 million, down from $196.00 million in the previous period[23]

荣安地产股份有限公司 2025 年第三季度报告 证券代码：000517 证券简称：荣安地产 公告编号：2025-028 荣安地产股份有限公司 2025 年第三季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重 大遗漏。 重要内容提示： 1.董事会及董事、高级管理人员保证季度报告的真实、准确、完整，不存在虚假记载、误 导性陈述或重大遗漏，并承担个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明：保证季度报 告中财务信息的真实、准确、完整。 3.第三季度财务会计报告是否经过审计 □是 否 一、主要财务数据 （一） 主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □是 否 | | 本报告期 | 本报告期比上年 | 年初至报告期末 | 年初至报告期末 | | --- | --- | --- | --- | --- | | | | 同期增减 | | 比上年同期增减 | | 营业收入（元） | 644,448,147.46 | -80.36% | 4,539,462,734.6 3 | -73.56% | | 归属 ...

证券代码：002142 证券简称：宁波银行 公告编号：2025-038 优先股代码：140001、140007 优先股简称：宁行优01、宁行优02 宁波银行股份有限公司 2025 年第三季度报告 本公司及董事会全体成员保证信息披露内容的真实、准确和完 整，没有虚假记载、误导性陈述或者重大遗漏。 重要内容提示： 1、公司董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、 准确、完整，不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法 律责任。 注：1、客户贷款及垫款、客户存款数据根据国家金融监督管理总局监管口径计算。 2、公司董事长陆华裕先生、行长庄灵君先生、主管会计工作负责人罗维开 先生及会计机构负责人胡海东先生声明：保证季度报告中财务信息的真实、准确、 完整。 3、公司 2025 年第三季度报告未经审计。 一、主要财务数据 （一）主要会计数据和财务指标 | | 2025 年 7-9 月 | 比上年同期增减 | 2025 年 1-9 月 | 比上年同期增减 | | --- | --- | --- | --- | --- | | 营业收入（百万元） | 17,816 | 9.19% | 54, ...

Financial Performance - Q3 2025 revenue reached ¥266,318,308.08, an increase of 7.27% year-over-year[5] - Net profit attributable to shareholders was ¥51,481,646.54, up 21.85% compared to the same period last year[5] - Net profit excluding non-recurring gains and losses was ¥49,531,944.69, reflecting a 23.53% increase year-over-year[5] - Total operating revenue for the third quarter reached ¥772,283,628.77, an increase of 6.5% compared to ¥727,111,638.35 in the previous period[13] - The net profit for the current period is CNY 174,888,593.70, an increase of 11.5% compared to CNY 156,893,135.76 in the previous period[15] - The operating profit for the current period is CNY 231,096,199.50, up from CNY 202,264,268.60, reflecting a growth of 14.3%[15] - The total comprehensive income attributable to the parent company is CNY 140,735,506.57, compared to CNY 124,268,539.31, indicating a rise of 13.3%[15] Earnings Per Share - Basic earnings per share for the period were ¥0.1059, an increase of 21.19% year-over-year[5] - Diluted earnings per share were ¥0.1055, reflecting a 23.34% increase compared to the same period last year[5] - The basic earnings per share increased to CNY 0.2895 from CNY 0.2568, representing a growth of 12.0%[15] Assets and Liabilities - Total assets at the end of the reporting period amounted to ¥5,382,346,746.68, representing a 3.72% increase from the end of the previous year[5] - Total assets increased to ¥5,382,346,746.68 from ¥5,189,189,456.29, marking a growth of 3.7%[12] - Non-current assets totaled ¥4,451,637,891.12, up from ¥4,380,449,074.81, reflecting a rise of 1.6%[11] - Total liabilities increased to ¥1,348,545,403.57 from ¥1,274,511,249.61, which is an increase of 5.8%[12] - The company's equity attributable to shareholders rose to ¥3,378,168,765.37 from ¥3,271,108,819.96, indicating a growth of 3.3%[12] Cash Flow - Cash flow from operating activities for the year-to-date was ¥231,587,492.00, up 13.05%[5] - Cash flow from operating activities generated a net amount of CNY 231,587,492.00, compared to CNY 204,858,677.16 in the previous period, marking an increase of 13.0%[16] - Cash flow from investing activities resulted in a net outflow of CNY 8,049,555.64, an improvement from a net outflow of CNY 139,507,850.44 in the previous period[17] - Cash flow from financing activities generated a net inflow of CNY 33,408,294.48, compared to a net outflow of CNY 182,521,768.64 in the previous period[17] - The total cash and cash equivalents at the end of the period amounted to CNY 541,311,248.03, up from CNY 294,975,236.55 at the end of the previous period[17] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 44,950[9] Government Subsidies - Government subsidies recognized in the current period amounted to ¥2,374,877.59[6] Investment Income - The company reported a net investment income of ¥9,465,816.34, down from ¥16,262,872.19, reflecting a decrease of 41.1%[13] Credit Impairment - The company reported a decrease in credit impairment losses to CNY 4,094,149.71 from CNY 4,458,985.93, reflecting a reduction of 8.2%[15] Mergers and Acquisitions - The company did not report any net profit from the merged entity prior to the merger, indicating no impact on the current financial results from this activity[15]

Financial Performance - The company's operating revenue for the third quarter was ¥37,015,530.15, representing a year-on-year increase of 0.52%[4] - The total profit for the quarter was a loss of ¥54,848,430.68, with a cumulative loss of ¥193,407,150.71 for the year-to-date[4] - The net profit attributable to shareholders for the quarter was a loss of ¥54,861,654.71, with a year-to-date loss of ¥193,536,147.26[4] - Total operating revenue for the first three quarters of 2025 reached ¥103,985,283.24, an increase of 6.9% compared to ¥97,562,309.83 in the same period of 2024[20] - Net loss for the first three quarters of 2025 was ¥193,536,147.26, compared to a net loss of ¥291,296,145.99 in the same period of 2024, indicating an improvement of 33.6%[21] - The basic and diluted earnings per share for the quarter were both -¥0.08[5] - The basic and diluted earnings per share for the first three quarters of 2025 were both -¥0.30, an improvement from -¥0.44 in the same period of 2024[21] Research and Development - Research and development expenses totaled ¥56,333,880.25 for the quarter, a decrease of 27.85% compared to the previous year[5] - The ratio of R&D expenses to operating revenue was 152.19%, down 59.84 percentage points from the previous year[5] - Research and development expenses for the first three quarters of 2025 were ¥172,747,166.04, down from ¥244,246,074.92 in 2024, a decrease of 29.3%[20] Assets and Liabilities - Total assets at the end of the quarter were ¥726,934,188.94, a decrease of 14.39% from the end of the previous year[5] - Total current assets decreased from 748,661,957.20 RMB to 640,046,361.72 RMB, a decline of approximately 14.5%[15] - Total liabilities increased from 335,037,523.23 RMB to 400,211,748.73 RMB, an increase of approximately 19.5%[16] - The company reported a total of ¥2,366,460.10 in non-recurring gains and losses for the quarter[8] - The company's total liabilities increased to ¥469,380,110.62 from ¥410,164,907.91, an increase of 14.4%[20] - Total assets decreased from 849,128,659.62 RMB to 726,934,188.94 RMB, a decrease of about 14.4%[16] Cash Flow - Cash flow from operating activities showed a net outflow of ¥165,628,026.86, an improvement from a net outflow of ¥293,485,930.62 in the previous year[24] - Cash inflow from investment activities totaled ¥1,930,610,524.90, compared to ¥1,904,622,936.40 in the same period of 2024, reflecting a slight increase[24] - Cash inflow from financing activities was $91,702,238.69, down from $100,000,000.00, while cash outflow for financing activities increased to $37,650,658.55 from $26,070,254.51, resulting in a net cash flow from financing activities of $54,051,580.14, down from $73,929,745.49[25] - The net increase in cash and cash equivalents was $63,700,257.64, compared to $116,538,132.46 in the previous period, with an ending cash balance of $337,032,548.26, up from $254,014,785.61[25] - The impact of exchange rate changes on cash and cash equivalents was a decrease of $1,608,325.68, an improvement from a decrease of $3,394,068.68 in the prior period[25] Shareholder Information - Total number of common shareholders at the end of the reporting period is 16,492[12] - Genie Pharma holds 10.92% of shares, totaling 71,572,817 shares[12] - The company has no significant changes in the top ten shareholders or their shareholding status[13]

Financial Performance - The company's operating revenue for Q3 2025 reached ¥5,031,850,801.87, representing a year-on-year increase of 6.48%[5] - Net profit attributable to shareholders was ¥92,797,723.25, up 49.14% compared to the same period last year[5] - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥90,104,355.70, reflecting a 43.01% increase year-on-year[5] - Basic and diluted earnings per share both stood at ¥0.26, marking a 49.14% increase from the previous year[5] - Total operating revenue for the current period reached ¥14,860,753,939.01, an increase of 10.2% compared to ¥13,487,182,811.91 in the previous period[20] - Net profit for the current period was ¥284,049,040.09, representing a 43.3% increase from ¥198,181,282.78 in the previous period[22] - The net profit attributable to shareholders of the parent company was ¥229,833,549.09, compared to ¥158,499,162.85, marking a growth of 45.0%[22] - Basic and diluted earnings per share for the current period were both ¥0.64, up from ¥0.44 in the previous period[22] Assets and Liabilities - Total assets at the end of the reporting period amounted to ¥14,686,136,571.84, a 12.00% increase from the end of the previous year[5] - Total liabilities increased to ¥12,266,187,059.91 from ¥11,335,476,422.64, reflecting a growth of 8.2%[18] - Shareholders' equity attributable to the parent company reached ¥2,077,221,495.65, up 40.24% from the previous year-end[5] - Total equity attributable to shareholders of the parent company rose to ¥2,077,221,495.65, compared to ¥1,481,229,497.57, an increase of 40.2%[18] - The company has a total of 14.18 billion in current assets, up from 12.60 billion, reflecting a growth of approximately 12.6%[17] - Non-current assets totaled CNY 510.35 million, slightly down from CNY 516.49 million, indicating a decrease of about 1.5%[17] Cash Flow - The net cash flow from operating activities for the year-to-date was ¥50,576,688.13, showing a significant increase of 104.63% compared to the same period last year[5] - Operating cash inflow for the current period reached ¥17,599,539,011.49, an increase of 6.06% from ¥15,650,057,820.67 in the previous period[25] - Net cash flow from operating activities was ¥50,576,688.13, a significant recovery from a negative cash flow of ¥-1,092,588,441.89 in the previous period[25] - Cash inflow from financing activities amounted to ¥4,133,187,948.57, an increase of 6.73% from ¥3,873,360,806.34 in the previous period[27] - The ending balance of cash and cash equivalents increased to ¥1,787,466,702.66, compared to ¥903,432,646.05 in the previous period[27] - Cash received from other financing activities was ¥49,992,256.33, with no previous amount reported[27] Shareholder Information - The company reported a total of 37,987 common shareholders at the end of the reporting period[10] - The largest shareholder, Xiamen Jianfa Medical, holds a 43.37% stake, while the second-largest shareholder, Pingxiang Changheyuan Investment Management, holds 26.80%[12] Initial Public Offering - The company completed its initial public offering during the reporting period, which contributed to the increase in shareholders' equity[9] - The company successfully completed its initial public offering (IPO) of 63,193,277 shares on September 25, 2025, under the stock code "301584" on the Shenzhen Stock Exchange[14] Operational Insights - The increase in net profit is attributed to the growth in the company's SPD management services business[9] - The company has plans for market expansion and new product development as part of its growth strategy moving forward[14] - The company reported a significant increase in tax payable, which rose to ¥86,554,671.54 from ¥52,066,299.53, a growth of 66.2%[18] - The company has ongoing research and development expenses of ¥18,081,750.52, slightly up from ¥17,235,616.66, indicating continued investment in innovation[21] Inventory and Receivables - Accounts receivable increased significantly to CNY 8.05 billion from CNY 6.47 billion, representing a growth of approximately 24.3%[17] - Inventory decreased to CNY 3.29 billion from CNY 3.48 billion, showing a decline of about 4.4%[17] - Short-term borrowings slightly decreased to CNY 3.77 billion from CNY 3.85 billion, a reduction of approximately 2.9%[17] Financial Reporting - Cash outflow from investment activities totaled ¥53,310,612.12, compared to ¥51,417,469.32 in the previous period, resulting in a net cash outflow of ¥53,278,391.12[25] - The company has not audited its third-quarter financial report[28]

Revenue and Profit - The company's revenue for Q3 2025 was ¥111,819,836.83, a decrease of 59.17% compared to the same period last year[3]. - Net profit attributable to shareholders reached ¥1,576,469,980.20, an increase of 2,199.10% year-on-year, primarily due to the sale of controlling interest in Silex Microsystems AB[3]. - The net profit excluding non-recurring gains and losses was -¥234,970,682.04, a decline of 198.67% compared to the previous year[3]. - Basic and diluted earnings per share were both ¥2.1530, reflecting a significant increase of 2,198.44% year-on-year[3]. - Net profit surged by 956.23% to ¥1,514,419,926.65, driven by various factors including the sale of Swedish Silex equity[9]. - Operating profit for the current period is ¥1,508,470,715.05, compared to a loss of ¥171,604,666.28 in the previous period[26]. - The net profit attributable to the parent company shareholders is approximately ¥1.58 billion, a decrease of ¥117.77 million compared to the previous period[27]. - The total comprehensive income amounts to approximately ¥1.65 billion, down by ¥192.02 million from the previous period[27]. Assets and Liabilities - Total assets increased to ¥8,919,148,229.60, up 27.21% from the end of the previous year[3]. - Total assets reached ¥8,919,148,229.60, up from ¥7,011,337,774.25, indicating a growth of 27.2%[23]. - Total liabilities increased to ¥1,805,372,835.75 from ¥1,622,173,986.62, reflecting a rise of 11.3%[23]. - Shareholder equity rose to ¥6,803,314,903.29, marking a 38.18% increase compared to the previous year-end[3]. - Owner's equity totaled ¥7,113,775,393.85, an increase from ¥5,389,163,787.63, representing a growth of 32.1%[23]. Cash Flow - Cash flow from operating activities for the year-to-date was ¥21,431,027.37, down 88.17% from the previous year[3]. - The net cash flow from operating activities decreased by 88.17% to ¥21,431,027.37 compared to the previous period[11]. - Cash flow from investing activities generated a net cash flow of approximately ¥1.13 billion, compared to a negative cash flow of ¥513.41 million in the previous period[29]. - The net cash flow from financing activities increased by 355.60% to ¥507,204,278.11, driven by the repayment of bank loans and financing lease debts[12]. - The company reported a net increase in cash and cash equivalents of ¥1,656,288,643.68, an increase of 830.39% compared to the previous period[12]. - The ending balance of cash and cash equivalents is approximately ¥2.27 billion, up from ¥718.88 million at the end of the previous period[30]. Investments and Acquisitions - The company completed the sale of its controlling interest in Silex Microsystems AB in July 2025, impacting both net profit and revenue significantly[3]. - The company acquired a controlling interest in Qingdao Zhancheng Technology Co., which contributed to a 420.62% increase in prepayments[7]. - Long-term equity investments increased by 310.60% to ¥2,384,953,421.10 as a result of revaluation at fair value after losing control[8]. - The company acquired 9.50% equity in its subsidiary Silex Beijing for a total price of CNY 32,370.96 million[18]. - The company approved the acquisition of 56.24% equity in Qingdao Zhancheng Technology Co., Ltd. for CNY 15,747.20 million, increasing its total ownership to 61.00%[19]. Operational Performance - Total operating costs rose by 31.33% to ¥1,295,910,449.94, influenced by comprehensive factors[9]. - Management expenses skyrocketed by 402.97% to ¥509,536,436.82, primarily due to equity incentive costs triggered by the sale of Swedish Silex[9]. - Research and development expenses for the current period were ¥295,258,407.47, compared to ¥274,553,380.58 in the previous period, indicating an increase in investment in innovation[26]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 76,168[13]. - The largest shareholder, Yang Yunchun, holds 24.46% of the shares, with 134,307,539 shares pledged[13]. Other Financial Metrics - Cash inflow from investment activities increased significantly by 26,136.98% to ¥1,715,953,057.62, primarily due to the full transaction price received from the sale of Silex shares[11]. - Cash received from investment income surged by 612.51% to ¥40,882,501.93, attributed to increased returns from long-term equity investments[11]. - Other comprehensive income after tax increased by 1,016.96% to ¥138,872,923.22, driven by various factors[10]. - Total comprehensive income surged by 961.02% to ¥1,653,292,849.87, reflecting strong financial performance[10].

安徽华恒生物科技股份有限公司2025 年第三季度报告 证券代码：688639 证券简称：华恒生物 安徽华恒生物科技股份有限公司 2025 年第三季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 公司董事会及董事、高级管理人员保证季度报告内容的真实、准确、完整，不存在虚假记载、误 导性陈述或重大遗漏，并承担个别和连带的法律责任。 公司负责人郭恒华、主管会计工作负责人樊义及会计机构负责人朱修发（会计主管人员）保证季 度报告中财务信息的真实、准确、完整。 第三季度财务报表是否经审计 □是 √否 一、主要财务数据 （一） 主要会计数据和财务指标 | | | | | 单位：元 | 币种：人民币 | | --- | --- | --- | --- | --- | --- | | | | | 本报告期比 | | 年初至报告期 | | 项目 | | 本报告期 | 上年同期增 | 年初至报告期末 | 末比上年同期 | | | | | 减变动幅度 | | 增减变动幅度 | | | | | (%) | | (%) | | ...

城发环境股份有限公司 2025 年第三季度报告 证券代码：000885 证券简称：城发环境 公告编号：2025-064 城发环境股份有限公司 2025 年第三季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 重要内容提示： 1.董事会及董事、高级管理人员保证季度报告的真实、准确、完整，不存在虚假记载、误导性陈述或重大遗漏，并承担 个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明：保证季度报告中财务信息的真实、准确、完 整。 3.第三季度财务会计报告是否经过审计 □是 否 一、主要财务数据 （一） 主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □是 否 城发环境股份有限公司 2025 年第三季度报告 | | | | 单位：元 | | --- | --- | --- | --- | | 项目 | 本报告期金额 | 年初至报告期期末金额 | 说明 | | 计入当期损益的政府补助（与公司正常经营业务密切 相关、符合国家政策规定、按照确定的标准享有、对 公司损益产生持续影响的政府补助除外） | 5, ...